Relmada Therapeutics, Inc. RLMD
3.84 USD +0.26 +7.26%
At close
3.75 -0.09 -2.34%
Pre-market · Nov 3, 8:02 AM ET
- YTD
- -20.50%
- 1 year
- +74.55%
- Open
- 3.61
- Prev close
- 3.58
- Mkt cap
- 409.61M
- Vol
- 2.26M
- Avg vol
- 1.34M
- EPS
- -0.98
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.60
- High
- 3.93
- Forward P/E
- -0.19
- Beta
- 0.41
- Short ratio
- 4.52
- Inst. own
- 46.06%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.53
- 200-d avg
- 3.33
- 1y target
- 0.86667
5D chart
Chart tools
Chart is warming up
The five-day price history for RLMD has not been loaded yet. Try again in a moment.
Altman Z-Score
13.25 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 2
P/E -3.3×
P/S 0.0×
P/B 2.2×
P/FCF -4.2×
EV/EBITDA -3.3×
EV/Sales 0.0×
FCF Yield -24.0%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -66.3%
ROIC -67.5%
ROA -61.0%
Revenue 0.0%
Operating Income 29.6%
EPS (diluted) 45.3%
Free Cash Flow 11.5%
Current Ratio 14.6×
Quick Ratio 14.6×
Debt / Equity 0.0×
Net Debt / EBITDA 0.1×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31
